Neutrophil-to-lymphocyte ratio as a predictive biomarker for moderate-severe ARDS in severe COVID-19 patients
Open Access
- 5 June 2020
- journal article
- letter
- Published by Springer Science and Business Media LLC in Critical Care
- Vol. 24 (1), 1-4
- https://doi.org/10.1186/s13054-020-03007-0
Abstract
Trial registrationChiCTR, ChiCTR2000029758. Registered 12 February 2020 - Retrospectively registeredFunding Information
- West China Hospital (HX2019nCoV027)
This publication has 6 references indexed in Scilit:
- COVID-19 Does Not Lead to a "Typical" Acute Respiratory Distress SyndromeAmerican Journal of Respiratory and Critical Care Medicine, 2020
- Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19Journal of Infection, 2020
- Critical Care for Severe COVID-19: A Population-based Study from a Province with Low Case-fatality Rate in ChinaPublished by Cold Spring Harbor Laboratory ,2020
- Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseasesThe Lancet Respiratory Medicine, 2020
- Preparing for COVID-19: early experience from an intensive care unit in SingaporeCritical Care, 2020
- Acute Respiratory Distress SyndromeJAMA, 2012